If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
66.50    -1.60 (-2.35%)
Bid:
65.40
Ask:
66.60
Spread: 1.20 (1.835%)
Market Cap: £587.48m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Scrip Dividend Reference Price

18 Aug 2022 09:25

RNS Number : 4623W
IP Group PLC
18 August 2022
 

FOR RELEASE ON

18 August 2022

 

IP Group plc

 

Scrip Dividend Reference Price

 

Further to the release of the Company's Half-Yearly Results on 03 August 2022, the Company announces that the Scrip Reference Share Price for the 2022 interim dividend, payable on 19 September 2022, is 80.5 pence. Defined terms in this announcement are as defined in the Scrip Dividend Terms and Conditions which are available on the Company's website at https://www.ipgroupplc.com/investor-relations/shareholder-information/scripdividend.

 

The Scrip Reference Share Price is the price at which the Company's Ordinary Shares will be issued to shareholders who have elected to receive dividends in the form of newly issued, fully paid shares in the Company in lieu of cash through participation in the optional Scrip Dividend Scheme.

 

The Scrip Reference Share Price is the average of the mid closing price of the Company's Ordinary Shares, as derived from the London Stock Exchange Daily Official List, for the five dealing days commencing on the relevant ex-dividend date (being 11, 12, 15, 16 and 17 August 2022).

 

Any shareholder entitled to the 2022 interim dividend who has not already completed a Scrip Dividend Mandate Form or a Dividend Election Input Message in CREST and is intending to do so, should refer to the Scrip Dividend Scheme Terms and Conditions.

 

The final time and date for receipt of Scrip Dividend Mandates and Dividend Election Input Messages in CREST is 5:00pm on 26 August 2022.

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBKFBBFBKKBFD
Date   Source Headline
23rd Nov 20216:18 pmRNSPortfolio company ieso raises £39m
22nd Nov 20216:27 pmRNSTransaction in Own Shares
19th Nov 20215:41 pmRNSTransaction in Own Shares
18th Nov 20216:07 pmRNSTransaction in Own Shares
17th Nov 20215:43 pmRNSTransaction in Own Shares
17th Nov 20212:08 pmRNSPortfolio company Ultraleap raises £60 million
16th Nov 20215:46 pmRNSTransaction in Own Shares
15th Nov 20215:34 pmRNSTransaction in Own Shares
15th Nov 20217:00 amRNSTransaction in Own Shares
11th Nov 20216:11 pmRNSTransaction in Own Shares
11th Nov 20217:09 amRNSPortfolio company RFC Power signs JDA with Ceres
10th Nov 20216:22 pmRNSTransaction in Own Shares
9th Nov 20216:12 pmRNSTransaction in Own Shares
8th Nov 20216:11 pmRNSTransaction in Own Shares
5th Nov 20215:24 pmRNSTransaction in Own Shares
4th Nov 20216:08 pmRNSTransaction in Own Shares
3rd Nov 20216:27 pmRNSTransaction in Own Shares
2nd Nov 20216:15 pmRNSTransaction in Own Shares
1st Nov 20216:12 pmRNSTransaction in Own Shares
29th Oct 20215:35 pmRNSTransaction in Own Shares
29th Oct 20212:02 pmRNSPortfolio co Hinge Health completes $400m round
28th Oct 20216:21 pmRNSTransaction in Own Shares
27th Oct 20215:43 pmRNSDirector/PDMR Shareholding
27th Oct 20215:25 pmRNSTransaction in Own Shares
26th Oct 20215:56 pmRNSTransaction in Own Shares
25th Oct 20216:28 pmRNSTransaction in Own Shares
25th Oct 20217:00 amRNSAdditional fair value gain of £27.5m
22nd Oct 20216:29 pmRNSTransaction in Own Shares
21st Oct 20216:00 pmRNSTransaction in Own Shares
20th Oct 20215:56 pmRNSTransaction in Own Shares
19th Oct 20216:31 pmRNSTransaction in Own Shares
19th Oct 20217:00 amRNSTransaction in Own Shares
18th Oct 20217:00 amRNSTransaction in Own Shares
14th Oct 20216:27 pmRNSTransaction in Own Shares
13th Oct 20216:22 pmRNSTransaction in Own Shares
13th Oct 202111:36 amRNSDirector Declaration
13th Oct 20219:03 amRNSHolding(s) in Company
12th Oct 20216:20 pmRNSTransaction in Own Shares
12th Oct 20212:09 pmRNSDirector/PDMR Shareholding
12th Oct 20217:00 amRNSTransaction in Own Shares
11th Oct 20217:41 amRNSTransaction in Own Shares
8th Oct 20217:00 amRNSShare buyback programme
6th Oct 20217:00 amRNSBoard changes
5th Oct 20214:44 pmRNSHolding(s) in Company
30th Sep 20214:11 pmRNSTotal Voting Rights
30th Sep 20217:45 amRNSIP Group generates £84m from Oxford Nanopore IPO
27th Sep 202112:40 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:57 pmRNSFurther re Scrip Dividend
16th Sep 20217:08 amRNSOxford Nanopore confirms ITF; MoU with Oracle
10th Sep 20215:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.